anmelden
SLI
2.318,31
PKT
-8,99
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.05.23 | Richemont Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 04.05.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | Nestlé Market-Perform | Bernstein Research | |
| 04.05.23 | Swiss Re Sector Perform | RBC Capital Markets | |
| 04.05.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 04.05.23 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.05.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 02.05.23 | Richemont Buy | UBS AG | |
| 02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
| 28.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Outperform | Credit Suisse Group | |
| 27.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 26.04.23 | UBS Underweight | Barclays Capital | |
| 26.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 26.04.23 | UBS Underweight | Barclays Capital | |
| 26.04.23 | Novartis Underperform | Credit Suisse Group | |
| 26.04.23 | Nestlé Neutral | Credit Suisse Group | |
| 26.04.23 | Novartis Underweight | Barclays Capital | |
| 26.04.23 | Nestlé Buy | UBS AG | |
| 26.04.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 26.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 26.04.23 | Nestlé Buy | Deutsche Bank AG | |
| 26.04.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 26.04.23 | Novartis Buy | Deutsche Bank AG | |
| 26.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 26.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 25.04.23 | Richemont Outperform | RBC Capital Markets | |
| 25.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Nestlé Underperform | RBC Capital Markets | |
| 25.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets |
